NSC16168 is primarily utilized in research settings for its potential as an anticancer agent. It has been studied for its ability to inhibit the growth of certain cancer cells, particularly in experimental models. Researchers are investigating its mechanism of action, which may involve targeting specific pathways or proteins involved in tumor progression. Additionally, it is explored for its potential to enhance the efficacy of other chemotherapeutic agents when used in combination therapies. Its role in preclinical studies contributes to the development of novel treatment strategies for various cancers.